← Open Payments lookup

TODD FAGO: Open Payments

NPI 1730195744 · YORK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$423 in 24 payments from 10 companies in 2025. Trend: 2023 $504 · 2024 $437 · 2025 $423

Food & beverage: $423
CompanyPaymentsAmount
ABBVIE INC.12$203
Lilly USA, LLC3$46
Astellas Pharma US Inc1$34
Bayer Healthcare Pharmaceuticals Inc.2$29
Otsuka America Pharmaceutical, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
E.R. Squibb & Sons, L.L.C.1$19
Seqirus USA Inc1$19
PFIZER INC.1$16
Novo Nordisk Inc1$14

Products named: UBRELVY, Veozah, Kerendia, MOUNJARO, AVYCAZ, TEFLARO, VRAYLAR, REXULTI.

Industry payments across NE — which companies pay providers there.